Select Page

EAGAN, Minn., Oct. 06, 2020 (GLOBE NEWSWIRE) — Predictive Oncology (NASDAQ:POAI), a knowledge-driven company focused on applying artificial intelligence (“AI”) to personalized medicine and drug discovery, is pleased to release the CEO’s letter to the shareholders.